Syndax Pharmaceuticals SNDX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's total assets?
- Syndax Pharmaceuticals (SNDX) reported total assets of $472.67M in Q1 2026.
- How has Syndax Pharmaceuticals's total assets changed year-over-year?
- Syndax Pharmaceuticals's total assets decreased by 26.2% year-over-year, from $640.71M to $472.67M.
- What is the long-term trend for Syndax Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's total assets has grown at a 12.0% compound annual growth rate (CAGR), from $300.61M to $529.71M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.